- Home
- RL vs GMAB Comparison
RL vs GMAB Comparison
Compare RL & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RL | GMAB |
|---|---|---|
| Founded | 1967 | 1999 |
| Country | United States | Denmark |
| Employees | N/A | 3088 |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 16.5B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | RL | GMAB |
|---|---|---|
| Price | $395.83 | $29.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | ★ $406.75 | $39.56 |
| AVG Volume (30 Days) | 553.3K | ★ 2.0M |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | ★ 30.15 | N/A |
| EPS | ★ 15.11 | N/A |
| Revenue | ★ $8,114,500,000.00 | N/A |
| Revenue This Year | $15.92 | $17.85 |
| Revenue Next Year | $5.80 | $16.04 |
| P/E Ratio | $25.22 | ★ $1.90 |
| Revenue Growth | ★ 14.63 | N/A |
| 52 Week Low | $282.80 | $21.00 |
| 52 Week High | $421.60 | $35.43 |
Technical Indicators
Market Signals| Indicator | RL | GMAB |
|---|---|---|
| Relative Strength Index (RSI) | 53.67 | 62.60 |
| Support Level | $366.75 | $28.01 |
| Resistance Level | $421.60 | $29.62 |
| Average True Range (ATR) | 11.57 | 0.58 |
| MACD | 0.77 | -0.04 |
| Stochastic Oscillator | 82.44 | 85.30 |
Price Performance
Historical ComparisonAbout RL Ralph Lauren Corporation
Founded by designer Ralph Lauren (current executive chairman and chief creative officer) in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle merchandise in North America, Europe, and Asia. Best known for its iconic polo shirts, its products also include other types of apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.
About GMAB Genmab A/S ADS
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.